MAP2K1 and neoplasm: Previous studies have demonstrated that kinases such as RET, MAP2K1, ALK, and FGF can promote tumor growth via helping tumor cells to evade the immune system by downregulating HLA-I expression (Brea et al., 2016; Oh et al., 2019).